INVESTIGATE AND LOOK AT THE EXAMPLE OF DYSLIPIDAEMIA IN MALE AND FEMALE PATIENTS OF TYPE 2 DIABETES

Background: Diabetes mellitus is a disorder having consequences for glucose and lipid profile. Objective: To investigate and look at the example of dyslipidaemia in male and female patients of type 2 diabetes. Structure: An observational relative investigation. Setting and spot of study: This examination was led in Jinnah Hospital Lahore, over aperiod of a half year from January, 2018 to June, 2018. Procedure: An aggregate of hundred analyzed instances of type 2 diabetes were arbitrarily chosen for study. The individuals who had hyperlipidaemia because of optional causes, for example, nephrotic disorder, hypothyroidism and medications and so forth were barred. Blood tests were taken for fasting and arbitrary sugar and fasting lipid profile. For measurable examination understudy "T" test at 5% dimension of essentialness was connected. Results: The female patients were observed to be overweight and hypertensive and they had uncontrolled hyperglycemia too. Their systolic circulatory strain was 150±25.75 mm/Hg and diastolic B.P was 90.6±17.6mm/Hg. The mean blood glucose focus was 246.64±105mg//dL. The mean fixation oflipids was essentially raised among females when contrasted with guys. On the whole in female patients the estimations of LDL-C, triglycerides and HDL-C was 191±31.81 mg/dL, 179±93mg/dL and 32±2.4mg/dL individually, all in high hazard go. LDL: HDL proportion was 6.0. Despite the fact that in male patients the mean fixation ofLDL was 174±41mg/dL and it was in high hazard classification, however HDL-C was fringe (35.2mg/dL), and triglycerides were inside typical range. LDL: HDL proportion was additionally in adequate range. Conclusion: The female diabetics were hypertensive, overweight and hadmore uncontrolled hyperglycemia alongside dyslipidaemia when contrasted with male. The example of dyslipidaemia found in these female patients was increment in LDL­ Candstrikingly diminished HDL-C level. Key words: Gender, Dyslipidaemia, type 2 diabetes